Skip to main navigation Skip to search Skip to main content

Biallelic inactivation of the RIZ1 gene in human gastric cancer

  • Yutaka Tokumaru
  • , Shuji Nomoto
  • , Carmen Jerónimo
  • , Rui Henrique
  • , Susan Harden
  • , Barry Trink
  • , David Sidransky

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The distal short arm of chromosome 1 is commonly deleted in a variety of human neoplasms including gastrointestinal cancer. Genetic alterations of the retinoblastoma protein-interacting zing-finger gene (RIZ)1 including loss of heterozygosity (LOH) at 1p36, frameshift mutations, and promoter hypermethylation were reported previously in several cancers. In this study, we evaluated RIZ1 in 30 primary gastric cancers and found frameshift mutations in two cases (6.7%). Moreover, using real-time quantitative methylation-specific PCR, methylation of the RIZ1 promoter was detected in 11 (37%) cases. In all 11 cases with methylation, inactivation of the second allele occurred through frameshift mutation, LOH or promoter methylation. Our results suggest that RIZ1 is a specific target of inactivation in human gastric cancer.

Original languageEnglish
Pages (from-to)6954-6958
Number of pages5
JournalOncogene
Volume22
Issue number44
DOIs
Publication statusPublished - 9 Oct 2003
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Gastric cancer tumor suppressor gene
  • Gene silencing
  • Hypermethylation
  • RIZ1

Cite this